Chile approves J&J's COVID-19 vaccine for emergency use_老虎社区_美港股上老虎

Chile approves J&J's COVID-19 vaccine for emergency use

Reuters2021-06-11

SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

ToMars
·2021-06-11
Nice
回复
点赞
举报
Jfamily
·2021-06-11
Hope this brings improvement to the locals
回复
1
举报
Finree
·2021-06-11
Still consider relative cheap for vaccine stock?
回复
点赞
举报
Oddleo
·2021-06-11
More alternatives to vaccine[Sick]
回复
1
举报
中国ChinaATM
·2021-06-11
Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment'CHINA ATM SOAR TO THE MOON!!'
回复
点赞
举报
TK360
·2021-06-11
Great
回复
1
举报
MengKeng
·2021-06-11
Good, it will drive other companies to also develop 1 shot vaccine as well.
回复
点赞
举报
Khoo12
·2021-06-11
Yes
回复
1
举报
Eslechia
·2021-06-11
👍🏼
回复
2
举报
Tslverde
·2021-06-11
Good
回复
1
举报
Tslverde
·2021-06-11
Get more vaccinated!! Like
回复
3
举报
YauDK
·2021-06-11
Oh ye ye pls like and comment
回复
2
举报
收起
- Oddleo:
  Sure done
  2021-06-11
  回复
  举报
JeffTai
·2021-06-11
Good
回复
4
举报
收起
- YauDK:
  Oh Ye ye
  2021-06-11
  回复
  举报
SSVC
·2021-06-11
Good Appreciate your response and comments Thanks
回复
3
举报
收起
- Oddleo:
  Sure thing[Grin]
  2021-06-11
  回复
  举报
50160107Acct
·2021-06-11
Good
回复
3
举报
Y1968
·2021-06-11
Just jabs lar
回复
2
举报
KTC
·2021-06-11
One more vaccines
回复
4
举报
收起
- Desmond669:
  Good
  2021-06-11
  回复
  举报
sanjai
·2021-06-11
Sure
回复
1
举报
henghm
·2021-06-11
Like and comment
回复
3
举报
收起
- MumJ:
  please reply
  2021-06-11
  回复
  举报
- Pinnnn:
  like and reply plz
  2021-06-11
  回复
  举报
- Singman:
  pls do same to me.
  2021-06-11
  回复
  举报
查看更多 1 条评论
Toon
·2021-06-11
Good job. Hope everything turns better!
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2142278954?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-11 06:59","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2142278954","market":"us","top_or_hot":-1,"title":"Chile approves J&J's COVID-19 vaccine for emergency use","media":"Reuters","content":"<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","article_id":"2142278954","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","pubTimestamp":1623365990,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生"},"translate_title":"智利批准强生新冠疫苗紧急使用","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":0.9},"content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":188089425,"gmtCreate":1623416229667,"gmtModify":1634033528327,"author":{"id":"3570092809336734","authorId":"3570092809336734","name":"ToMars","avatar":"https://static.tigerbbs.com/7cad4ddeab0622dd29ed1d7c76c750b8","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3570092809336734","authorIdStr":"3570092809336734"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/188089425","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181119285,"gmtCreate":1623377977647,"gmtModify":1631884325337,"author":{"id":"3581650998573030","authorId":"3581650998573030","name":"Jfamily","avatar":"https://static.tigerbbs.com/a3aebdda0a7db817f943bd9c7990f11b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581650998573030","authorIdStr":"3581650998573030"},"htmlText":"Hope this brings improvement to the locals","listText":"Hope this brings improvement to the locals","text":"Hope this brings improvement to the locals","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181119285","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181380212,"gmtCreate":1623373941736,"gmtModify":1634034059095,"author":{"id":"3578179845340728","authorId":"3578179845340728","name":"Finree","avatar":"https://static.tigerbbs.com/90e0afcf8b7bfce8ce34256846ba6981","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3578179845340728","authorIdStr":"3578179845340728"},"htmlText":"Still consider relative cheap for vaccine stock?&nbsp;","listText":"Still consider relative cheap for vaccine stock?&nbsp;","text":"Still consider relative cheap for vaccine stock?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181380212","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181941867,"gmtCreate":1623371854259,"gmtModify":1634034105939,"author":{"id":"3582365143818595","authorId":"3582365143818595","name":"Oddleo","avatar":"https://static.tigerbbs.com/569e40b38ccc6665e8895b488137078c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582365143818595","authorIdStr":"3582365143818595"},"htmlText":"More alternatives to vaccine[Sick]&nbsp;","listText":"More alternatives to vaccine[Sick]&nbsp;","text":"More alternatives to vaccine[Sick]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181941867","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181940951,"gmtCreate":1623371754173,"gmtModify":1634034108615,"author":{"id":"3584867430360256","authorId":"3584867430360256","name":"中国ChinaATM","avatar":"https://static.tigerbbs.com/bd214125064b4d25501bb48cef2fb529","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3584867430360256","authorIdStr":"3584867430360256"},"htmlText":"Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment'CHINA ATM SOAR TO THE MOON!!'","listText":"Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment'CHINA ATM SOAR TO THE MOON!!'","text":"Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment'CHINA ATM SOAR TO THE MOON!!'","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181940951","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181911227,"gmtCreate":1623370213569,"gmtModify":1634034150549,"author":{"id":"3574766349354741","authorId":"3574766349354741","name":"TK360","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3574766349354741","authorIdStr":"3574766349354741"},"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181911227","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181931702,"gmtCreate":1623369918206,"gmtModify":1634034160239,"author":{"id":"3582668988155006","authorId":"3582668988155006","name":"MengKeng","avatar":"https://static.tigerbbs.com/daf999525f61ba41d3c13b0ed728eb77","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582668988155006","authorIdStr":"3582668988155006"},"htmlText":"Good, it will drive other companies to also develop 1 shot vaccine as well.","listText":"Good, it will drive other companies to also develop 1 shot vaccine as well.","text":"Good, it will drive other companies to also develop 1 shot vaccine as well.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181931702","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181939539,"gmtCreate":1623369878921,"gmtModify":1634034162391,"author":{"id":"3564738902623228","authorId":"3564738902623228","name":"Khoo12","avatar":"https://static.tigerbbs.com/a1637796379aeed1538616117eb09330","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3564738902623228","authorIdStr":"3564738902623228"},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181939539","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181991011,"gmtCreate":1623369632533,"gmtModify":1634034170128,"author":{"id":"3586039357257394","authorId":"3586039357257394","name":"Eslechia","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586039357257394","authorIdStr":"3586039357257394"},"htmlText":"👍🏼","listText":"👍🏼","text":"👍🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181991011","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181902448,"gmtCreate":1623369472384,"gmtModify":1634034176452,"author":{"id":"3556329315079497","authorId":"3556329315079497","name":"Tslverde","avatar":"https://static.tigerbbs.com/5f52f5991ed363792008cd868f78181c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3556329315079497","authorIdStr":"3556329315079497"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181902448","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181906519,"gmtCreate":1623369452732,"gmtModify":1631887210559,"author":{"id":"3556329315079497","authorId":"3556329315079497","name":"Tslverde","avatar":"https://static.tigerbbs.com/5f52f5991ed363792008cd868f78181c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3556329315079497","authorIdStr":"3556329315079497"},"htmlText":"Get more vaccinated!! Like","listText":"Get more vaccinated!! Like","text":"Get more vaccinated!! Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181906519","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181076293,"gmtCreate":1623369152012,"gmtModify":1634034186629,"author":{"id":"3580072870029753","authorId":"3580072870029753","name":"YauDK","avatar":"https://static.tigerbbs.com/4e00c10df4000c04392220903422d15f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580072870029753","authorIdStr":"3580072870029753"},"htmlText":"Oh ye ye pls like and comment&nbsp;","listText":"Oh ye ye pls like and comment&nbsp;","text":"Oh ye ye pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/181076293","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4675349,"gmtCreate":1623371780001,"gmtModify":1635328599179,"authorId":3582365143818595,"author":{"id":3582365143818595,"idStr":"3582365143818595","authorId":3582365143818595,"name":"Oddleo","avatar":"https://static.tigerbbs.com/569e40b38ccc6665e8895b488137078c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181076293,"type":1,"supId":0,"prevId":0,"content":"Sure done","text":"Sure done","html":"Sure done"}],"langContent":"EN"},{"id":181071713,"gmtCreate":1623369102932,"gmtModify":1634034188260,"author":{"id":"3581504334066898","authorId":"3581504334066898","name":"JeffTai","avatar":"https://static.tigerbbs.com/eaf357935d6e8ef3744f3d94312f0a64","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581504334066898","authorIdStr":"3581504334066898"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/181071713","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4674132,"gmtCreate":1623369163971,"gmtModify":1635328731202,"authorId":3580072870029753,"author":{"id":3580072870029753,"idStr":"3580072870029753","authorId":3580072870029753,"name":"YauDK","avatar":"https://static.tigerbbs.com/4e00c10df4000c04392220903422d15f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181071713,"type":1,"supId":0,"prevId":0,"content":"Oh Ye ye ","text":"Oh Ye ye ","html":"Oh Ye ye "}],"langContent":"EN"},{"id":181044001,"gmtCreate":1623368891503,"gmtModify":1634034193348,"author":{"id":"3574906731000207","authorId":"3574906731000207","name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3574906731000207","authorIdStr":"3574906731000207"},"htmlText":"Good Appreciate your response and comments Thanks&nbsp;","listText":"Good Appreciate your response and comments Thanks&nbsp;","text":"Good Appreciate your response and comments Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/181044001","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4675366,"gmtCreate":1623371809735,"gmtModify":1635328597467,"authorId":3582365143818595,"author":{"id":3582365143818595,"idStr":"3582365143818595","authorId":3582365143818595,"name":"Oddleo","avatar":"https://static.tigerbbs.com/569e40b38ccc6665e8895b488137078c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181044001,"type":1,"supId":0,"prevId":0,"content":"Sure thing[Grin]","text":"Sure thing[Grin]","html":"Sure thing[Grin]"}],"langContent":"EN"},{"id":181055321,"gmtCreate":1623368642063,"gmtModify":1634034202957,"author":{"id":"3582706615498692","authorId":"3582706615498692","name":"50160107Acct","avatar":"https://static.tigerbbs.com/6be9d18c4a63434e372aa39f7de3ec12","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582706615498692","authorIdStr":"3582706615498692"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181055321","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181058735,"gmtCreate":1623368586427,"gmtModify":1631884220477,"author":{"id":"3581727244675977","authorId":"3581727244675977","name":"Y1968","avatar":"https://static.tigerbbs.com/f6a22f88deb287b757cb3e60419d2882","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3581727244675977","authorIdStr":"3581727244675977"},"htmlText":"Just jabs lar","listText":"Just jabs lar","text":"Just jabs lar","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181058735","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181053832,"gmtCreate":1623368470126,"gmtModify":1631883987631,"author":{"id":"3550435859846504","authorId":"3550435859846504","name":"KTC","avatar":"https://static.tigerbbs.com/3623e77f867273576bf9781b05f7bf6c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3550435859846504","authorIdStr":"3550435859846504"},"htmlText":"One more vaccines&nbsp;","listText":"One more vaccines&nbsp;","text":"One more vaccines","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/181053832","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4673864,"gmtCreate":1623368514047,"gmtModify":1635328758443,"authorId":3562118563279867,"author":{"id":3562118563279867,"idStr":"3562118563279867","authorId":3562118563279867,"name":"Desmond669","avatar":"https://static.tigerbbs.com/e2484115c94d3471cb46f20ea7598b4a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181053832,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"}],"langContent":"EN"},{"id":181027451,"gmtCreate":1623368360273,"gmtModify":1634034209778,"author":{"id":"3585723690109803","authorId":"3585723690109803","name":"sanjai","avatar":"https://static.tigerbbs.com/23cf2db3251ec4be4ef04ee0f6a7bbfd","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3585723690109803","authorIdStr":"3585723690109803"},"htmlText":"Sure","listText":"Sure","text":"Sure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181027451","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181027393,"gmtCreate":1623368334912,"gmtModify":1634034210259,"author":{"id":"3578451349447391","authorId":"3578451349447391","name":"henghm","avatar":"https://static.tigerbbs.com/ca41bf4eae57d98d93422d97c7246c98","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3578451349447391","authorIdStr":"3578451349447391"},"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/181027393","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4673878,"gmtCreate":1623368565485,"gmtModify":1635328757035,"authorId":3582080974533433,"author":{"id":3582080974533433,"idStr":"3582080974533433","authorId":3582080974533433,"name":"MumJ","avatar":"https://static.tigerbbs.com/a24a11fee66832dcfc9036c2b7a805e9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181027393,"type":1,"supId":0,"prevId":0,"content":"please reply","text":"please reply","html":"please reply"},{"id":4673976,"gmtCreate":1623368808283,"gmtModify":1635328747112,"authorId":3579839069912835,"author":{"id":3579839069912835,"idStr":"3579839069912835","authorId":3579839069912835,"name":"Pinnnn","avatar":"https://static.tigerbbs.com/feb1bdfc37216fbd6e61eb5ba4f68a17","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181027393,"type":1,"supId":4673878,"prevId":0,"content":"like and reply plz ","text":"like and reply plz ","html":"like and reply plz "},{"id":4674064,"gmtCreate":1623369000842,"gmtModify":1635328738485,"authorId":3575125836760247,"author":{"id":3575125836760247,"idStr":"3575125836760247","authorId":3575125836760247,"name":"Singman","avatar":"https://static.tigerbbs.com/d770feb757705f2d631d2d5f381ae07b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181027393,"type":1,"supId":0,"prevId":0,"content":"pls do same to me.","text":"pls do same to me.","html":"pls do same to me."},{"id":4707165,"gmtCreate":1623478209096,"gmtModify":1635325793030,"authorId":3582080974533433,"author":{"id":3582080974533433,"idStr":"3582080974533433","authorId":3582080974533433,"name":"MumJ","avatar":"https://static.tigerbbs.com/a24a11fee66832dcfc9036c2b7a805e9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181027393,"type":1,"supId":4674064,"prevId":0,"content":"done. like my comment <u>pls</u>","text":"done. like my comment <u>pls</u>","html":"done. like my comment <u>pls</u>"}],"langContent":"EN"},{"id":181028836,"gmtCreate":1623368128425,"gmtModify":1631884325389,"author":{"id":"3578796507103054","authorId":"3578796507103054","name":"Toon","avatar":"https://static.tigerbbs.com/f463c3513f746690f6ef65903c509241","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3578796507103054","authorIdStr":"3578796507103054"},"htmlText":"Good job. Hope everything turns better!","listText":"Good job. Hope everything turns better!","text":"Good job. Hope everything turns better!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181028836","repostId":2142278954,"repostType":4,"repost":{"id":"2142278954","pubTimestamp":1623365990,"share":"https://www.laohu8.com/m/news/2142278954?lang=&edition=full","pubTime":"2021-06-11 06:59","market":"us","language":"en","title":"Chile approves J&J's COVID-19 vaccine for emergency use","url":"https://stock-news.laohu8.com/highlight/detail?id=2142278954","media":"Reuters","summary":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved th","content":"<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson &amp; Johnson.</p>\n<p>The single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).</p>\n<p>\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.</p>\n<p>Chile hosted a trial of the Johnson &amp; Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.</p>\n<p>Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&amp;J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.</p>\n<p>The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&amp;J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.</p>\n<p>Chilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.</p>\n<p>To date, Chile has inoculated 11.2 million people, 75% of its target population, with at least <a href=\"https://laohu8.com/S/AONE\">one</a> dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chile approves J&J's COVID-19 vaccine for emergency use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChile approves J&J's COVID-19 vaccine for emergency use\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical ...</p>\n\n<a href=\"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://finance.yahoo.com/news/chile-approves-j-js-covid-225950893.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142278954","content_text":"SANTIAGO, June 10 (Reuters) - Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson.\nThe single-dose vaccines will arrive through the global COVAX mechanism, which distributes vaccines to low and middle-income countries and is supported by the World Health Organization (WHO) and Global Vaccines Alliance (GAVI).\n\"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over,\" the institute said in a statement.\nChile hosted a trial of the Johnson & Johnson vaccine, along with five other Latin American countries, and had thrashed out a bilateral deal to buy the jab, but it failed to materialise amid pressure on supply from the United States and Europe, which had already ordered large batches.\nEarlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.\nThe GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.\nChilean authorities have already authorized four vaccines for emergency use in Chile: Pfizer BioNTech, Sinovac, AstraZeneca/Oxford and CanSino.\nTo date, Chile has inoculated 11.2 million people, 75% of its target population, with at least one dose of COVID-19 vaccine, while 8.7 million, 57.8% of the target, have been fully inoculated. (Reporting by Fabian Cambero, writing by Aislinn Laing; Editing by Aurora Ellis)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":96,"commentSize":23,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}